Associate Principal Engineer, Process Development
Michael Gilman is an associate principal engineer, process development at Verve Therapeutics. Prior to joining Verve, Michael worked at Moderna, in manufacturing sciences and technology supporting COVID vaccine manufacturing, and earlier in mRNA process development. Previously, he also held roles in clinical and commercial manufacturing at Alexion. He has a master’s degree in cell and bioprocess engineering from Tufts University and a bachelor’s degree in chemical engineering from the University of New Hampshire.